Latest Advances in the Diagnosis and Management of Vitreo-Retinal Disorders—Second Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 64
Special Issue Editor
Interests: retinal diseases; vitreoretinal diseases; vitrectomy; vitreoretinal surgery; diabetic retinopathy; retinal vein occlusion
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
I am pleased to invite you to contribute to this Special Issue, entitled "Latest Advances in the Diagnosis and Management of Vitreo-Retinal Disorders—Second Edition". For more details on the first volume, in which we published five papers, please visit https://www.mdpi.com/journal/jcm/special_issues/K7J958P42Q.
In recent years, the management of retinal and choroidal diseases has undergone major advances in diagnosis and treatment. In the area of diagnosis, the past two decades have seen significant advances in optical coherence tomography (OCT) as well as OCT angiography and color scanning laser ophthalmoscopy, which have become popular worldwide. Thus, multimodal imaging has improved the accuracy of diagnosis and the understanding of pathological conditions. The development of testing equipment also means an increase in the number of images of healthy and diseased eyes.
Treatments for diseases have also evolved dramatically. No one would dispute that the first of these are anti-vascular endothelial growth factor (VEGF) drugs. Anti-VEGF drugs have become a mainstay in the treatment of retinal diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and macular edema, and have greatly expanded the potential of drug therapy for these diseases.
This Special Issue invites a wide range of research related to ophthalmic diagnosis and management. Our aim is for this Special Issue to be of help in the diagnosis and management of vitreo-retinal disorders and to assist in your future research.
Prof. Dr. Takeshi Iwase
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vitreo-retinal disorders
- optical coherence tomography (OCT)
- OCT angiography
- anti-VEGF therapy
- image analysis
- vitrectomy
